Cite
HARVARD Citation
Gendrot, M. et al. (2020). Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate. International journal of infectious diseases. pp. 437-440. [Online].